scispace - formally typeset
W

Willem H. van Harten

Researcher at Netherlands Cancer Institute

Publications -  39
Citations -  1377

Willem H. van Harten is an academic researcher from Netherlands Cancer Institute. The author has contributed to research in topics: Randomized controlled trial & Cost effectiveness. The author has an hindex of 19, co-authored 39 publications receiving 1080 citations. Previous affiliations of Willem H. van Harten include Imperial College Healthcare & University of Twente.

Papers
More filters
Journal ArticleDOI

Effectiveness of Multidimensional Cancer Survivor Rehabilitation and Cost-Effectiveness of Cancer Rehabilitation in General: A Systematic Review

TL;DR: Multidimensional rehabilitation programs were found to be effective, but not more effective than monodimensional interventions, and not on all outcome measures, in cancer survivors and cost-effectiveness of cancer rehabilitation in general.
Journal ArticleDOI

Empowerment of Cancer Survivors Through Information Technology: An Integrative Review

TL;DR: It is shown that IT services may especially contribute to empowerment by providing knowledge, and the components of empowerment could be used to develop IT services for cancer survivors.
Journal ArticleDOI

Actual costs of cancer drugs in 15 European countries.

TL;DR: In summary, overly restrictive eligibility criteria hinder accrual and jeopardise the generalisability and usefulness of study results in the broader population.
Journal ArticleDOI

Why do patients choose (not) to participate in an exercise trial during adjuvant chemotherapy for breast cancer

TL;DR: Factors associated significantly with the decision (not) to participate in a randomized controlled trial of physical exercise during adjuvant chemotherapy for breast cancer are identified.